Avedro, Inc. today announced the completion of all one-year follow-up visits for patients enrolled in its two multi-center Phase III studies evaluating the safety and efficacy of corneal collagen cross-linking for the treatment of progressive keratocon…
Month: May 2011
Seeking A Cure For Premature Baby Blindness
Scientists from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast are teaming up to develop a cure to an illness that can lead to blindness in premature babies, thanks to funding from children’s charity Action Medi…
Oraya Therapeutics Completes Enrollment In Pioneering Sham-Controlled Study Of Radiation Therapy For Wet AMD
Oraya Therapeutics, Inc. today announced that it has completed enrollment of its INTREPID clinical trial in Europe. The study is the first sham-controlled, double-masked trial to evaluate the effectiveness and safety of radiation therapy in conjunction…
10 Totally Cool and Incredibly Useful Medical Gadgets and Apps
New developments help improve medical care and doctors find many of them fun to use. Medscape Business of Medicine
With Ocular Melanoma, It Is Status Quo, Research Shows
Investigators try to identify prognostic factors and to reduce recurrence and metastasis of intractable ocular tumors. Medscape Medical News
Increased Demand For Visual Healthcare ADE Prevention Platform
Visual Healthcare Corp. (the “Company”) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a…
Increased Demand For Visual Healthcare ADE Prevention Platform
Visual Healthcare Corp. (the “Company”) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a…
Increased Demand For Visual Healthcare ADE Prevention Platform
Visual Healthcare Corp. (the “Company”) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a…
Increased Demand For Visual Healthcare ADE Prevention Platform
Visual Healthcare Corp. (the “Company”) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a…
Increased Demand For Visual Healthcare ADE Prevention Platform
Visual Healthcare Corp. (the “Company”) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused version as a…
For Innovative Glaucoma Testing, NJIT And UMDNJ License Personal Tonometer Technology
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, …
Nanocyrstalline Diamond Aerogel Set To Improve Optics
By combining high pressure with high temperature, Livermore researchers have created a nanocyrstalline diamond aerogel that could improve the optics for something as big as a telescope or as small as the lenses in eyeglasses. Aerogels are a class of ma…
ASCRS 2011: Program Highlights
Featured Article
Seeking A Cure For Premature Baby Blindness
Scientists from the School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast are teaming up to develop a cure to an illness that can lead to blindness in premature babies, thanks to funding from children’s charity Action Medi…
For Innovative Glaucoma Testing, NJIT And UMDNJ License Personal Tonometer Technology
NJIT and UMDNJ have executed a license agreement with The Incubation Factory, St. Louis, MO, covering their personal tonometer technology on which a patent is pending. The tonometer was developed by a research team led by NJIT Professor Gordon Thomas, …
Anti-VEGF Drug Showing Promise for Diabetic Macular Edema
In a phase II study of patients with diabetic macular edema (DME), intravitreal injections of a fusion protein called VEGF Trap-Eye proved superior to focal/grid laser treatment, researchers report. Reuters Health Information
Retinal Signs in Older Patients Portend Future Disability
A link has been found between retinal microvascular signs and functional disability in older adults. Medscape Medical News
Researchers Develop 3D Sensing Wheelchair for the Visually Impaired
Researchers from LuleƄ University of Technology in Sweden are developing a wheelchair that senses its environment in 3D and transmits this information to its user. It features a laser scanner that uses a time-of-flight technique to map its surroundings in 3D. A haptic robot, held in the left hand, translates this data to useful information for the (Read more...)
Merck acquires Inspire Pharmaceuticals
Merck, known as MSD outside the United States and Canada, announced today that it is has completed its acquisition of Inspire Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing ophthalmic products, for $…
Crystalens Post-LASIK
Featured Article